Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin in the skin helps protect against damage from stress and UV rays, and could be used to treat certain skin conditions.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The piRNA pathway genes are crucial in early development and may influence sex differentiation through hormone regulation.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Fernblock® helps protect skin cells from pollution and stress, reducing inflammation and damage.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Low-frequency electromagnetic fields can boost molecules related to hair growth in human skin cells.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The lncRNA LOXL1-AS1 may help diagnose and treat androgenic alopecia.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New genes linked to male pattern baldness were found on chromosome 20p11.

Lactiplantibacillus plantarum ZJUIDS51 can help regrow hair and improve scalp health in androgenic alopecia.

The new microneedle system improves hair growth in alopecia treatment.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

Intraoperative corticosteroids reduce swelling, and early care lowers folliculitis risk in hair transplant donor sites.